Why Did I Get Cancer? What Science Actually Says

If you've recently been diagnosed with cancer, there's a good chance one of the first things you asked — or maybe screamed inside your head — was why me? It's one of the most human questions there is. And for a long time, medicine didn't have a great answer.

The honest truth is that cancer doesn't always have a single, clear cause. But science has made enormous progress in recent years in understanding where cancers come from — and that understanding can genuinely help you make sense of your diagnosis. Not to assign blame (more on that in a minute), but because understanding the "why" can shape your treatment, your family's risk picture, and how you think about what comes next.

So let's talk about it. There are three main pathways through which cancer-causing mutations develop in our bodies. Think of them as three different roads that can all lead to the same destination. Most people's cancer involves a combination of more than one.

First, a Quick Word About Mutations

Cancer is, at its core, a disease of mutations — changes in the DNA inside our cells. Specifically, mutations in genes that control how cells grow, divide, and die. When enough of these mutations stack up in the right (or wrong) genes, a cell can start behaving badly: dividing uncontrollably, ignoring signals to stop, and eventually forming a tumor.

Here's what's important to understand: mutations happen constantly. Every time one of your cells divides, there's a chance of a small copying error. Your body has remarkable machinery to catch and fix most of these errors, but it isn't perfect. Cancer is what can happen when those errors accumulate over time.

Now, let's look at the three main sources of those mutations.

Road #1: The Genes You Were Born With (Hereditary Mutations)

Some people inherit mutations from their parents that put them at significantly higher risk of developing certain cancers. These are called germline mutations because they're present in every cell in the body from the moment of conception.

The most well-known examples are mutations in the BRCA1 and BRCA2 genes. Normally, these genes act as tumor suppressors — they help repair damaged DNA. When a person inherits a faulty copy, that repair system is compromised, and the risk of breast, ovarian, pancreatic, and prostate cancer goes up substantially. A 2024 review in JAMA highlighted that identifying BRCA mutations not only guides cancer risk management but opens doors to targeted therapies like PARP inhibitors — drugs specifically designed to exploit this DNA repair deficiency.¹

Lynch syndrome is another important example. It involves inherited mutations in genes responsible for "mismatch repair" — essentially, the spell-checker of your DNA. People with Lynch syndrome face a lifetime colorectal cancer risk as high as 78%, along with elevated risks for endometrial, ovarian, and other cancers. Updated NCCN guidelines now recommend hereditary cancer testing for all colorectal cancer patients regardless of age or family history, a significant shift from earlier practice.²

Here's something important to keep in mind: hereditary cancers account for only about 5–10% of all cancer cases. So while family history matters and genetic testing is increasingly valuable, most cancers — even in people who have a family history — are not primarily driven by inherited mutations.

Road #2: The Environment and Lifestyle (Environmental Mutations)

This is the category most people are most familiar with, and for good reason. A landmark 2026 analysis published in Nature Medicine estimated that roughly 38% of all cancer cases globally were attributable to modifiable risk factors in 2022 — things like tobacco use, alcohol consumption, high body mass index, ultraviolet radiation, air pollution, and infections from agents like HPV and H. pylori.³

Tobacco smoking remains the single largest contributor, particularly for lung, head and neck, and bladder cancers. Alcohol is a significant risk factor for liver, esophageal, and colorectal cancers. Obesity is increasingly recognized as a driver of at least 13 cancer types. UV radiation drives melanoma and skin cancers.

These exposures cause cancer by leaving characteristic "footprints" in tumor DNA, called mutational signatures. Researchers can now sequence a tumor's genome and essentially read its history — identifying the molecular marks left by tobacco carcinogens, UV light, and other agents. A 2025 study in Nature Genetics analyzed 265 head and neck cancer genomes from eight countries and identified six distinct mutational signatures linked to tobacco smoke, and found that cases exposed to both tobacco and alcohol showed a compounding effect on DNA damage.⁴

This is not about blame. A sweeping 2022 Lancet analysis of cancer risk factors across 204 countries made the point explicitly: behavioral risk factors are strongly shaped by the environments people live in, and individuals with cancer should not be blamed for their disease.⁵ Knowing that an environmental factor played a role is useful for understanding your cancer — it's not a moral judgment.

Road #3: Random Mistakes During Cell Division (Replicative Mutations)

This is the part that surprises most people, and it's arguably the most important scientific development in cancer etiology of the past decade.

Every time one of your body's stem cells divides — something that happens billions of times throughout your lifetime — there's a small but nonzero chance that a copying error will slip through. These are called replicative (R) mutations, and they are, to a significant degree, unavoidable. They're not caused by anything you did or were exposed to. They are simply the biological cost of being a living organism whose cells must continuously renew themselves.

In a landmark paper published in Science, Tomasetti, Li, and Vogelstein studied 17 cancer types across 69 countries covering 4.8 billion people, and found a strong correlation (median r = 0.80) between cancer incidence and the number of normal stem cell divisions in a given tissue — regardless of geography or environment.⁶ This held true across North America, Europe, Asia, Africa, and Oceania. The message was striking: a tissue's cancer risk tracks closely with how often its stem cells divide, suggesting that the act of cell division itself is a major driver of cancer risk.

Their analysis also estimated the fraction of cancer-causing mutations attributable to each of the three sources. For lung adenocarcinoma — a cancer where 89% of cases are potentially preventable by eliminating environmental exposures — they calculated that approximately 35% of the actual driver gene mutations were still attributable to these unavoidable replicative errors. For pancreatic cancer, roughly 77% of driver mutations were estimated to arise from replication errors, not environment or heredity. For prostate cancer, that figure climbed to 95%.⁶

A 2022 mathematical modeling study in Nature Communications independently validated these findings, showing that endogenous mutational processes could account for about four-fifths of the variation in cancer risk across tissue types.⁷

What does this mean practically? It means that even when someone does "everything right" — no smoking, healthy weight, no family history — cancer can still develop. Not because of bad luck in a dismissive sense, but because DNA copying errors accumulate over a lifetime, and some of those errors can eventually hit a critical gene in a critical cell. This explains why cancer risk increases with age, why some cancers are more common in tissues with high cell turnover (like the colon and skin), and why cancers like brain, bone, and prostate have historically been hard to connect to any environmental cause.

So Which Road Brought You Here?

The honest answer, for most people, is some combination of all three — and we may not be able to fully untangle them.

Here's a framework that might help you think about it:

If your cancer has a strong hereditary component, you may have been referred for genetic counseling or tumor genetic testing. Mutations in BRCA1/2, Lynch syndrome genes (MLH1, MSH2, MSH6, PMS2), or other high-risk genes can be identified through blood or saliva testing. Knowing this matters enormously — not just for your own treatment, but for your family members who may want to pursue risk reduction strategies.

If your cancer is associated with a known environmental exposure, that information may be woven into your pathology report or treatment conversation. Lung cancers, for example, are often subtyped in ways that reflect their history. HPV-associated head and neck cancers behave differently than HPV-negative ones. This context shapes prognosis and treatment choices.

If your cancer seems to have come "out of nowhere" — no obvious environmental exposure, no family history — you are very much not alone. The science increasingly tells us this is often the story of replicative mutations: the accumulated errors of a body doing exactly what bodies do.

What This Means for Prevention and Early Detection

Understanding where cancer mutations come from doesn't mean throwing up our hands. It means being strategic.

Primary prevention — reducing your exposure to known environmental risk factors — is still the most powerful tool we have. Quitting smoking, limiting alcohol, maintaining a healthy weight, protecting yourself from UV exposure, and staying current on HPV and hepatitis vaccinations are all evidence-backed ways to reduce your risk of cancers that are environmentally driven. Global estimates suggest that around 4 in 10 cancers worldwide could potentially be prevented through these kinds of modifications.³

But for the significant fraction of cancers driven by replicative mutations — the ones that arise from the unavoidable biology of being human — early detection becomes the most critical tool. Cancers caught at an early stage are overwhelmingly more treatable. Screening programs for colorectal, breast, cervical, and lung cancers are specifically designed to catch these changes before they become life-threatening. And the field of liquid biopsy — detecting cancer signals in the blood before symptoms appear — is advancing rapidly with the goal of making early detection accessible across cancer types.

As Tomasetti and colleagues wrote: for cancers in which all mutations are the result of unavoidable replication errors, secondary prevention — meaning early detection and intervention — is the only option.⁶ That makes the conversation about screening not just a medical recommendation, but a genuinely life-saving one.

A Final Note on Blame

Please hear this: cancer is not your fault.

Even when an environmental factor contributed to your cancer, that doesn't mean you failed. Environmental exposures are shaped by where we live, what we're offered, what we're never warned about, and systems far larger than any individual. And as the science makes clear, even someone who avoided every known risk factor could still develop cancer from the random accumulation of replication errors over a lifetime.

The question "why did I get cancer?" is worth asking — not to assign blame, but because understanding your cancer's likely origins can help you and your care team make better decisions. It can help your family understand their own risk. And it can replace some of the "what did I do wrong?" with something more grounded in reality.

Cancer is complicated. Your body is not to blame. And the science is giving us better and better ways to understand, prevent, and treat it.

References

1. Cheng HH, et al. BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients. JAMA. Published online July 25, 2024. doi:10.1001/jama.2024.XXXX

2. NCCN Guidelines — Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2024. National Comprehensive Cancer Network. Updated April 2024.

3. Vignat J, et al. Global and regional cancer burden attributable to modifiable risk factors to inform prevention. Nature Medicine. 2026. doi:10.1038/s41591-026-04219-7

4. Torrens L, et al. The complexity of tobacco smoke-induced mutagenesis in head and neck cancer. Nature Genetics. 2025. doi:10.1038/s41588-025-02134-0

5. Tran KB, et al. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2022;400:563–591. doi:10.1016/S0140-6736(22)01438-6

6. Tomasetti C, Li L, Vogelstein B. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science. 2017;355(6331):1330–1334. doi:10.1126/science.aaf9011

7. Pastore A, et al. Evaluating cancer etiology and risk with a mathematical model of tumor evolution. Nature Communications. 2022;13:6349. doi:10.1038/s41467-022-34760-1

Becky Howard holds a PhD in Cancer Biology from Moffitt Cancer Center and has spent her career at the intersection of oncology science and patient communication. Making Sense of Cancer is her effort to bring the science to the people it matters most to — patients and their families.

This post is for educational purposes and does not constitute medical advice. Please discuss your specific diagnosis and risk factors with your oncology team.